Showing results (1841-1850 of 9,924) with videos related to
Sort By:
Pageof 993
Bone Marrow Transplantation|June 1, 1997
Effect of T cell subset dose on outcome of T cell-depleted bone marrow transplantationY Kawanishi, J Passweg, W R Drobyski, et al.Bone Marrow Transplantation|June 1, 1997
CD34 positive PBPC expanded ex vivo may not provide durable engraftment following myeloablative chemoradiotherapy regimensT L Holyoake, M J Alcorn, L Richmond, et al.Bone Marrow Transplantation|June 1, 1997
Engraftment and outcomes of patients receiving myeloablative therapy followed by autologous peripheral blood stem cells with a low CD34+ cell contentC H Weaver, J Potz, J Redmond, et al.Bone Marrow Transplantation|June 1, 1997
Early and fatal immune haemolysis after so-called 'minor' ABO-incompatible peripheral blood stem cell allotransplantationS Oziel-Taieb, C Faucher-Barbey, C Chabannon, et al.Bone Marrow Transplantation|June 1, 1997
Transplant of bone marrow and cord blood hematopoietic stem cells in pediatric practice, revisited according to the fundamental principles of bioethicsG R Burgio, F LocatelliBone Marrow Transplantation|June 1, 1997
GM-CSF-mobilized peripheral blood CD34+ cells differ from steady-state bone marrow CD34+ cells in adhesion molecule expressionT Watanabe, B Dave, D G Heimann, et al.Bone Marrow Transplantation|June 1, 1997
Haploidentical family member transplants for patients with chronic myeloid leukaemia: a report of the Chronic Leukaemia Working Party of off European Group for Blood and Marrow Transplantation (EBMT)D E Speiser, J Hermans, A van Biezen, et al.Bone Marrow Transplantation|June 1, 1997
Tumor cell contamination of peripheral blood stem cell transplants and bone marrow in high-risk breast cancer patientsR Schulze, M Schulze, A Wischnik, et al.Bone Marrow Transplantation|June 1, 1997
Prolonged remission of longstanding systemic lupus erythematosus after autologous bone marrow transplant for non-Hodgkin's lymphomaJ A Snowden, W N Patton, J L O'Donnell, et al.Bone Marrow Transplantation|June 1, 1997
Cryptosporidiosis after CD34-selected autologous peripheral blood stem cell transplantation (PBSCT). Treatment with paromomycin, azithromycin and recombinant human interleukin-2D Nachbaur, G Kropshofer, H Feichtinger, et al.Pageof 993